Researchers conducted a multivariate analysis to determine the factors that contribute to employment participation among women with early-stage breast cancer.
Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.
Among adults aged 20 to 54 years, increase in CRC mortality only seen in whites aged 30 to 54 years.
Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic GroupsJune 23, 2017
Follow-up after abnormal results on mammography is more likely to be delayed among Asian American women compared with white women, and varies between different Asian ethnicities.
A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.
Researchers summarize the program development, outcomes, and lessons learned from a program that provided cancer screening services for under/uninsured Asian Indio women.
Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other GroupsApril 27, 2017
Researchers found that low acculturated Latina women were moderately less satisfied with surgeon and oncology communication compared with other racial and ethnic groups.
Out of 7 nationality groups studied, only Japanese women didn't have an overall increase in the disease.
Although median survival is longer for Hispanic and black patients compared with white patients, health-related QoL is poor for minority patients.
Reporting of overall immediate breast reconstruction and of racial disparities varies significantly between SEER and 2 large US databases.
Cancer deaths within 1 month of diagnosis occur most often in patients younger than 1 years, especially among Blacks and Hispanics.
NCI awarded a $9 million grant to Barbara A. Karmanos Cancer Institute and Wayne State University to explore factors contributing to racial disparities in cancer.
Despite that most patients with newly diagnosed prostate cancer receive high-quality care, a racial disparity exists, a recent study has shown.
Race is not associated with the development of metastases in patients with nonmetastatic castration-resistant prostate cancer (CRPC), according to a recently published study.
Disparities in BRCA1/2 testing in black and white women is attributable to differences in physician recommendations, according to a recent study.
A new report from the U.S. Department of Health and Human Services finds improvements to infant mortality rates and number of insured citizens, but other problem areas persist.
Clear role expectations and organization support are vital for lay health advisors.
Lung Cancer Screening Criteria Need to Recognize Differences in Smoking Patterns of African AmericansApril 08, 2016
Screening for lung cancer may have a disparity between African Americans and whites due to differences in smoking habits.
Germline mutations to the RECQL gene were identified in 0.5% of patients with familial breast cancer in a Chinese population.
Disparities in some cancer mortality rates between African Americans and whites in the United States have decreased, but these differences remain in colorectal and breast cancers.
African-American pediatric patients with Hodgkin lymphoma still display a considerable survival disparity when compared to their white and Hispanic peers.
Differences in Cancer Rates Seen Among Asian American and Native Hawaiian/Pacific Islander PopulationsJanuary 29, 2016
Significant differences in cancer rates were found between Asian Americans and Native Hawaiians/Pacific Islanders (AANHPIs), according to a special report within Cancer Facts & Figures 2016.
Racial and ethnic variation is evident in lung cancer incidence and mortality among postmenopausal women, but other factors may also have an influence, according to a recent study.
Hospital-based physicians exhibit significantly fewer positive, rapport-building nonverbal cues with black patients than with white patients when discussing end-of-life care.
Adherence to cancer screening recommendations was not found to vary by race/ethnicity and body weight/obesity. In a focused look at the influence of body mass index (BMI) as a measure of obesity, some screening disparities may be decreasing.
Variations in cancer risk are likely due to differences in exposure to carcinogens, screening rates, and lifestyle factors.
Non-Hispanic black women with endometrial cancer display worse outcomes when compared to women in other racial/ethnic groups diagnosed with the same subtype of endometrial cancer.
In a study reviewing black women under 50 with invasive breast cancer, 12 percent had BRCA1 or BRCA2 mutations.
The shortage of minority physicians may affect U.S. patient care, experts say.
Non-Hispanic black women have higher endometrial cancer incidence and lower survival across all stages and subtypes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
- Colorectal Cancer Screening Rate Increased by Digital Self-Ordering
- Presence of Iris Pigmented Lesions Indicates Melanoma Risk
- A Witness to Letting Go: Nursing Care at the End of Life
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|